» Articles » PMID: 2882520

Superactive Octapeptide Somatostatin Analogs Containing Tryptophan at Position 1

Overview
Specialty Science
Date 1987 Apr 1
PMID 2882520
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

We synthesized a series of octapeptide analogs of somatostatin, containing N-terminal tryptophan or another amino acid followed by the hexapeptide sequences Cys-Phe-D-Trp-Lys-Thr-Cys or Cys-Tyr-D-Trp-Lys-Val-Cys and a C-terminal threoninamide or tryptophanamide. After purification by HPLC, the inhibitory activities of these analogs on the release of growth hormone (somatotropin) in rats were determined in vivo. The eight octapeptides with an N-terminal tryptophan residue were found to have a greater inhibitory effect than somatostatin. The most potent of these analogs, D-Trp-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2, was 94.3 times more active than somatostatin. The other analogs, in order of decreasing potency, were Ac-Trp-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2, D-Trp(For)-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2, D-Trp-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2, Ac-Trp(For)-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2, Ac-Trp-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2, D-Trp-Cys-Phe-D-Trp-Lys-Thr-Cys-Trp-NH2, and D-Trp-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2. The growth hormone inhibitory activity of these analogs was from 53.7 to 11.6 times greater than that of somatostatin. The octapeptides containing D- or L-tryptophan at the N-terminus, phenylalanine at position 3, and threonine at position 6 exhibited a greater inhibitory effect on growth hormone release than that of the analogs with tyrosine and valine at positions 3 and 6, respectively. Substitution of D-tryptophan for D-phenylalanine at the N-terminus in the octapeptide containing phenylalanine in the third, threonine in the sixth, and threoninamide in the C-terminal position also increased the growth hormone-release inhibitory activity. Time-course assay showed that D-Trp-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2 (RC-98-I), in a dose of 1 microgram/kg of body weight, inhibited the release of growth hormone for at least 3 hr. In view of their high activity and prolonged duration of action, some of these analogs could be useful clinically.

Citing Articles

Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives.

Hohla F, Winder T, Greil R, Rick F, Block N, Schally A World J Gastroenterol. 2014; 20(20):6102-12.

PMID: 24876732 PMC: 4033449. DOI: 10.3748/wjg.v20.i20.6102.


Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.

Banks W, Schally A, Barrera C, Fasold M, Durham D, Csernus V Proc Natl Acad Sci U S A. 1990; 87(17):6762-6.

PMID: 1975697 PMC: 54617. DOI: 10.1073/pnas.87.17.6762.

References
1.
Rivier J, BRAZEAU P, Vale W, Guillemin R . Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity. J Med Chem. 1975; 18(2):123-6. DOI: 10.1021/jm00236a001. View

2.
Brown M, Rivier J, Vale W . Somatostatin: analogs with selected biological activities. Science. 1977; 196(4297):1467-9. DOI: 10.1126/science.867045. View

3.
Schally A, Coy D, Meyers C . Hypothalamic regulatory hormones. Annu Rev Biochem. 1978; 47:89-128. DOI: 10.1146/annurev.bi.47.070178.000513. View

4.
Murphy W, Heiman M, Lance V, Mezo I, Coy D . Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat. Biochem Biophys Res Commun. 1985; 132(3):922-8. DOI: 10.1016/0006-291x(85)91895-9. View

5.
Cai R, Szoke B, Lu R, Fu D, Redding T, Schally A . Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Proc Natl Acad Sci U S A. 1986; 83(6):1896-900. PMC: 323191. DOI: 10.1073/pnas.83.6.1896. View